Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

 

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Hereditary Hemorrhagic Telangiectasia Center

hht logo

The Johns Hopkins Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence is committed to superb patient and family care as well as state-of-the-art research. Our goals are to improve the health of our patients and families as well as to better the lives of those patients in the world that we may never meet.

We aim to do this by teaching other providers, educating patients and families and working to advance the state of medical knowledge. Our center includes over 30 full-time faculty members.

We hold clinical and research expertise in a broad range of conditions. For over 25 years, we have remained active in the treatment of patients and families with HHT. We hope this web site will answer some of your questions, but please contact us if you would like more information.

 

   
  
back to top button